Back
  1. Home
  2. Profile of Bianca E Silva (ULiège)
Profil

E Silva Bianca

GIGA Immunobiology - Hematology

Département des sciences cliniques > GIGA

Hématologie

See author's contact details
ORCID
0000-0001-8663-1804
Main Referenced Co-authors
Baron, Frédéric  (27)
Ehx, Grégory  (27)
Jassin, Mégane  (19)
Faville, Charline  (16)
Caers, Jo  (11)
Main Referenced Keywords
CAR-T (8); Hematology (4); Immunology (3); Multiple myeloma (3); Myélome multiple (3);
Main Referenced Disciplines
Hematology (22)
Immunology & infectious disease (5)
Oncology (3)
Biochemistry, biophysics & molecular biology (3)
Life sciences: Multidisciplinary, general & others (1)

Publications (total 28)

The most downloaded
61 downloads
E Silva, B., Zingoni, Z. M., Koekemoer, L., & Dahan-Moss, Y. (22 May 2021). Microbiota identified from preserved Anopheles. Malaria Journal, 20 (1). doi:10.1186/s12936-021-03754-7 https://hdl.handle.net/2268/291217

The most cited

23 citations (OpenAlex)

E Silva, B., Zingoni, Z. M., Koekemoer, L., & Dahan-Moss, Y. (22 May 2021). Microbiota identified from preserved Anopheles. Malaria Journal, 20 (1). doi:10.1186/s12936-021-03754-7 https://hdl.handle.net/2268/291217

E Silva, B.* , Daubry, A.* , Faville, C.* , De Voeght, A., Foguenne, J., Jassin, M., Kwan, O., Correia Da Cruz, L., Carriglio, G., Charles, S., Baron, F., Caers, J., Gothot, A., & Ehx, G. (2026). Biases introduced by Ficoll-based isolation in acute myeloid leukemia sample analyses support the use of hemolysis. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/342923. doi:10.64898/2026.02.11.705243
* These authors have contributed equally to this work.

E Silva, B.* , Daubry, A.* , Faville, C.* , De Voeght, A., Foguenne, J., Jassin, M., Kwan, O., Correia Da Cruz, L., Carriglio, G., Charles, S., Baron, F., Caers, J., Gothot, A., & Ehx, G. (2026). Biases introduced by Ficoll-based isolation in acute myeloid leukemia sample analyses support the use of hemolysis. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/341505.
* These authors have contributed equally to this work.

Faville, C., E Silva, B., Daubry, A., Correia Da Cruz, L., Carriglio, G., Charles, S., De Voeght, A., Fleron, M., Baiwir, D., Mazzucchelli, G., Fillet, M., Willems, L., Baron, F., & Ehx, G. (January 2026). Characterization of Immunogenic MHC-I epitopes presentation in acute myeloid leukemia drug-tolerant persisters [Paper presentation]. Televie Seminar 2026.

Jassin, M., Onkelinx, C., Bocuzzi, V., E Silva, B., Kwan, O., Block, A., Dubois, S., Daulne, C., Marcion, G., Ormenese, S., Di Valentin, E., Baron, F., GREGOIRE, C., Ehx, G., Nguyen, T. T., & Caers, J. (08 December 2025). Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma. Cells, 14 (24), 1944. doi:10.3390/cells14241944
Peer Reviewed verified by ORBi

Jassin, M., Onkelinx, C., E Silva, B., Bocuzzi, V., Block, A., Marcion, G., Baron, F., Di Valentin, E., Ehx, G., Nguyen, T. T., & Caers, J. (18 November 2025). Design of a novel NanoCAR construct that compares well with a conventional ScFv-based CAR targeting BCMA on multiple myeloma [Poster presentation]. Bis annual meeting.

Faville, C.* , E Silva, B.* , Baron, F., & Ehx, G. (19 March 2025). Use of Human Acute Myeloid Leukemia Cells to Study Graft-Versus-Leukemia Immunity in Xenogeneic Mouse Models of Graft-Versus-Host Disease. Methods in Molecular Biology, 2907, 359 - 375. doi:10.1007/978-1-0716-4430-0_17
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Faville, C., E Silva, B., Vilanova Mana, L., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M., Willems, L., & Ehx, G. (18 March 2025). Optimization Of An MHC-I immunoprecipitation Protocol For Mass Spectrometry Analyses Of Persister-Specific Antigens In Acute Myeloid Leukemia [Poster presentation]. EACR Conference "Persister Cells: from Bacteria to Cancer".

Jassin, M., E Silva, B., Bocuzzi, V., Block, A., Marcion, G., Baron, F., Di Valentin, E., Ehx, G., Caers, J., Nguyen, T. T., & Onkelinx, C. (06 February 2025). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. 7th European CAR T-cell Meeting, Strasbourg, France.

Jassin, M., Onkelinx, C., E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (29 January 2025). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. Séminaire Télévie 2025, Liège, Belgium.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Charles, S., Dubois, S., Baron, F., & Ehx, G. (2025). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. EACR Conference Persister Cells: from Bacteria to Cancer.

Faville, C., E Silva, B., Cobraiville, G., Ehx, G., Fillet, M., Baron, F., De Voeght, A., Vilanova Mana, L., Willems, L., Baiwir, D., & Mazzucchelli, G. (October 2024). Optimization of an MHC-I immunoprecipitation protocol for mass spectrometry analyses of persister-specific antigens in acute myeloid leukemia [Paper presentation]. yBIS: 1st annual meeting.

Faville, C., E Silva, B., Vilanova Mana, L., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M., Mazzucchelli, G., Ehx, G., Baiwir, D., & Willems, L. (September 2024). Optimization Of An MHC-I immunoprecipitation Protocol For Mass Spectrometry Analyses Of Persister-Specific Antigens In Acute Myeloid Leukemia [Poster presentation]. GIGA Day.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance. European Journal of Immunology. doi:10.1002/eji.202470200
Peer Reviewed verified by ORBi

Jassin, M., E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., Nguyen, T. T., & Onkelinx, C. (31 May 2024). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. Recent insights into Immuno-Oncology, Anvers, Belgium.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Paper presentation]. EDT-Immunology PhD Day.

Jassin, M., Onkelinx, C., E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (23 May 2024). Production and development of a new immunotherapeutic targeting multiple myeloma [Paper presentation]. EDT - Immunology Day 2024, Liège, Belgium.

Faville, C., E Silva, B., Baron, F., & Ehx, G. (2024). Use of human AML cells to study graft-versus-leukemia immunity in xenogeneic mouse models of GVHD. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/320359. doi:10.1101/2024.04.30.591828

Jassin, M., Bocuzzi, V., Nguyen, T. T., Onkelinx, C., E Silva, B., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., & Caers, J. (22 April 2024). Production and development of a new immunotherapeutic targeting multiple myeloma [Paper presentation]. YBis Research Seminars: Immunology-Oncology, Liège, Belgium.

Jassin, M., Chloé Onkelinx, E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (15 February 2024). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. EBMT - EHA 6th European CAR T-cell Meeting, Valence, Spain.

Jassin, M., Chloé Onkelinx, E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (06 February 2024). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. Séminaire Télévie 2024.

Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Poster presentation]. Télévie Seminar.
* These authors have contributed equally to this work.

Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Paper presentation]. Télévie Seminar.
* These authors have contributed equally to this work.

Noronha, N., Durette, C., Cahuzac, M., E Silva, B., Courtois, J., Humeau, J., Sauvat, A., Hardy, M.-P., Vincent, K., Laverdure, J.-P., Lanoix, J., Baron, F., Thibault, P., Perreault, C., & Ehx, G. (2024). Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia. Leukemia, 38, 1019-1031. doi:10.1038/s41375-024-02250-6
Peer Reviewed verified by ORBi

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. yBIS First Annual Meeting.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. GIGA Day 2024.

E Silva, B., Faville, C., Jassin, M., DUBOIS, S., De Voeght, A., Baron, F., & Ehx, G. (09 September 2023). Characterizing the immune recognition of chemo-persister blasts in acute myeloid leukemia [Poster presentation]. GIGA Day 2023.

Noronha, N., Durette, C., E Silva, B., Courtois, J., Humeau, J., Sauvat, A., Hardy, M.-P., Vincent, K., Laverdure, J.-P., Lanoix, J., Baron, F., Thibault, P.* , Perreault, C.* , & Ehx, G.*. (2022). Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/298893. doi:10.1101/2022.12.02.518683
* These authors have contributed equally to this work.

E Silva, B., Zingoni, Z. M., Koekemoer, L., & Dahan-Moss, Y. (22 May 2021). Microbiota identified from preserved Anopheles. Malaria Journal, 20 (1). doi:10.1186/s12936-021-03754-7
Peer Reviewed verified by ORBi

Contact ORBi